{
  "retracted": false,
  "timestamp": 1516579200000,
  "updates": [
    {
      "timestamp": 1585515371640,
      "identifier": {
        "doi": "10.1080/08037051.2018.1428781"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1080/08037051.2017.1412797"
  },
  "publisher": "Informa UK Limited",
  "title": "Correction to: Rakugi et al., A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension"
}
